Rapamycin regulates the phosphorylation of rictor

被引:52
作者
Akcakanat, Argun [1 ]
Singh, Gopal [1 ]
Hung, Mien-Chie [1 ]
Meric-Bernstam, Funda [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
关键词
rictor; mammalian target of rapamycin; mTOR complex 2; rapamycin;
D O I
10.1016/j.bbrc.2007.07.151
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian target of rapamycin (mTOR) is a central regulator of cell growth. mTOR exists in two functional complexes, mTORC1 and mTORC2. mTORC1 is rapamycin-sensitive, and results in phosphorylation of 4E-BP1 and S6K1. mTORC2 is proposed to regulate Akt Ser473 phosphorylation and be rapamycin-insensitive. mTORC2 consists of mTOR, mLST8, sin 1, Protor/PRR5, and the rapamycin insensitive companion of mTOR (rictor). Here, we show that rapamycin regulates the phosphorylation of rictor. Rapamycin-mediated rictor dephosphorylation is time and concentration dependent, and occurs at physiologically relevant rapamycin concentrations. siRNA knockdown of mTOR also leads to rictor dephosphorylation, suggesting that rictor phosphorylation is mediated by mTOR or one of its downstream targets. Rictor phosphorylation induced by serum, insulin and insulin-like growth factor is blocked by rapamycin. Rictor dephosphorylation is not associated with dephosphorylation of Akt Ser473. Further work is needed to better characterize the mechanism of rictor regulation and its role in rapamycin-mediated growth inhibition. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 16 条
  • [1] Role of glycogen synthase kinase 3β in rapamycin-mediated cell cycle regulation and chemosensitivity
    Dong, JJ
    Peng, JY
    Zhang, HX
    Mondesire, WH
    Jian, WG
    Mills, GB
    Hung, MC
    Meric-Bernstam, F
    [J]. CANCER RESEARCH, 2005, 65 (05) : 1961 - 1972
  • [2] mTOR•RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes
    Hresko, RC
    Mueckler, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (49) : 40406 - 40416
  • [3] Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
    Jacinto, E
    Loewith, R
    Schmidt, A
    Lin, S
    Rüegg, MA
    Hall, A
    Hall, MN
    [J]. NATURE CELL BIOLOGY, 2004, 6 (11) : 1122 - U30
  • [4] MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
    Kim, DH
    Sarbassov, DD
    Ali, SM
    King, JE
    Latek, RR
    Erdjument-Bromage, H
    Tempst, P
    Sabatini, DM
    [J]. CELL, 2002, 110 (02) : 163 - 175
  • [5] Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells
    Mondesire, WH
    Jian, WG
    Zhang, HX
    Ensor, J
    Hung, MC
    Mills, GB
    Meric-Bernstam, F
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 7031 - 7042
  • [6] Determinants of rapamycin sensitivity in breast cancer cells
    Noh, WC
    Mondesire, WH
    Peng, JY
    Jian, WG
    Zhang, HX
    Dong, JJ
    Mills, GB
    Hung, MC
    Meric-Bernstam, F
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (03) : 1013 - 1023
  • [7] mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
    O'Reilly, KE
    Rojo, F
    She, QB
    Solit, D
    Mills, GB
    Smith, D
    Lane, H
    Hofmann, F
    Hicklin, DJ
    Ludwig, DL
    Baselga, J
    Rosen, N
    [J]. CANCER RESEARCH, 2006, 66 (03) : 1500 - 1508
  • [8] Pearce LR, 2007, BIOCH J
  • [9] Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
    Phung, Thuy L.
    Ziv, Keren
    Dabydeen, Donnette
    Eyiah-Mensch, Godfred
    Riveros, Marcela
    Perruzzi, Carole
    Sun, Jingfang
    Monahan-Earley, Rita A.
    Shiojima, Ichiro
    Nagy, Janice A.
    Lin, Michelle I.
    Walsh, Kenneth
    Dvorak, Ann M.
    Briscoe, David M.
    Neeman, Michal
    Sessa, William C.
    Dvorak, Harold F.
    Benjamin, Laura E.
    [J]. CANCER CELL, 2006, 10 (02) : 159 - 170
  • [10] Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
    Sarbassov, DD
    Ali, SM
    Sengupta, S
    Sheen, JH
    Hsu, PP
    Bagley, AF
    Markhard, AL
    Sabatini, DM
    [J]. MOLECULAR CELL, 2006, 22 (02) : 159 - 168